Articles |
From the Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.
Correspondence to Garrett J. Gross, PhD, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226.
Abstract Previous results from our laboratory have suggested
that opioid receptors are involved in ischemic preconditioning
(PC) in rat heart. Furthermore, other investigators have suggested that
µ- and
-opioid receptors mediate analgesia and hypoxic
cerebral vasodilatation via opening of ATP-sensitive K+
(KATP) channels. Thus, the purpose of the present study
was to test the hypothesis that activation of opioid receptors mimics
the cardioprotective effect of ischemic PC and that this effect
is produced by activation of KATP channels in the rat
heart. Anesthetized open-chest Wistar rats were subjected
to six different protocols. All groups were subjected to 30 minutes of
occlusion and 2 hours of reperfusion. Ischemic PC was elicited
by three 5-minute occlusion periods interspersed with 5 minutes of
reperfusion. Similarly, morphine-induced PC was elicited by three
5-minute drug infusions (100 µg/kg IV) interspersed with 5-minute
drug-free periods before the prolonged 30-minute occlusion. Infarct
size (IS) as a percentage of the area at risk (AAR) was determined by
triphenyltetrazolium staining.
Ischemic PC and morphine infusions resulted in similar
reductions in IS/AAR from 56±5% to 11±3% and 12±5%, respectively
(P<.05). Administration of glibenclamide (0.3 mg/kg IV), a
KATP channel antagonist, or naloxone (3 mg/kg
IV), a nonselective opioid receptor antagonist, both
blocked the cardioprotective effects of morphine. These results
indicate that opioid receptor stimulation results in a reduction in
infarct size similar to that produced by ischemic PC. The
effect of morphine is most likely mediated via an opioid
receptor-KATP channellinked mechanism in the rat
heart, since glibenclamide abolished its protection.
Key Words: myocardial infarction ATP-sensitive K+ channels naloxone opioid receptors
This article has been cited by other articles:
![]() |
P. J. Franco, D. C. Fernandez, P. H. Sande, M. I. Keller Sarmiento, M. Chianelli, D. A. Saenz, and R. E. Rosenstein Effect of Bacterial Lipopolysaccharide on Ischemic Damage in the Rat Retina Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4604 - 4612. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meco, S. Cirri, C. Gallazzi, G. Magnani, and D. Cosseta Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 319 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kadoi Pharmacological Neuroprotection During Cardiac Surgery Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 167 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Steensrud, S. Muller, P. C. Endresen, and D. G. Sorlie Clinical testing of nicorandil supplemented normokalemic cardioplegic solution Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 521 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lessa and E. Tibirica Pharmacologic Evidence for the Involvement of Central and Peripheral Opioid Receptors in the Cardioprotective Effects of Fentanyl Anesth. Analg., October 1, 2006; 103(4): 815 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Tsutsumi, H. H. Patel, D. Huang, and D. M. Roth Role of 12-lipoxygenase in volatile anesthetic-induced delayed preconditioning in mice Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H979 - H983. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Gross and G. J. Gross Ligand triggers of classical preconditioning and postconditioning Cardiovasc Res, May 1, 2006; 70(2): 212 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frassdorf, N. C. Weber, D. Obal, O. Toma, J. Mullenheim, G. Kojda, B. Preckel, and W. Schlack Morphine Induces Late Cardioprotection in Rat Hearts In Vivo: The Involvement of Opioid Receptors and Nuclear Transcription Factor {kappa}B Anesth. Analg., October 1, 2005; 101(4): 934 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Zuurbier, O. Eerbeek, and A. J. Meijer Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H496 - H499. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiang, E. Shi, Y. Nakajima, S. Sato, K. Ohno, and H. Yue Cyclooxygenase-1 Mediates the Final Stage of Morphine-Induced Delayed Cardioprotection in Concert With Cyclooxygenase-2 J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1707 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cao, L. Liu, and D. M. Van Winkle Met5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1955 - H1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rongen, W. J.G. Oyen, B. P. Ramakers, N. P. Riksen, O. C. Boerman, N. Steinmetz, and P. Smits Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans Circulation, January 18, 2005; 111(2): 173 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barrere-Lemaire, N. Combes, C. Sportouch-Dukhan, S. Richard, J. Nargeot, and C. Piot Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H83 - H88. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaugg, M. C. Schaub, and P. Foex Myocardial injury and its prevention in the perioperative setting Br. J. Anaesth., July 1, 2004; 93(1): 21 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuzume, R. A. Wolff, K. Amakawa, K. Kuzume, and D. M. Van Winkle Sustained exogenous administration of Met5-enkephalin protects against infarction in vivo Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2463 - H2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaugg, E. Lucchinetti, C. Garcia, T. Pasch, D. R. Spahn, and M. C. Schaub Anaesthetics and cardiac preconditioning. Part II. Clinical implications Br. J. Anaesth., October 1, 2003; 91(4): 566 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Elmoselhi, A. Lukas, P. Ostadal, and N. S. Dhalla Preconditioning attenuates ischemia-reperfusion-induced remodeling of Na+-K+-ATPase in hearts Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1055 - H1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Singh and H. K. Saini Resident Cardiac Mast Cells and Ischemia-Reperfusion Injury Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 135 - 148. [Abstract] [PDF] |
||||
![]() |
J. A. Coles Jr., D. C. Sigg, and P. A. Iaizzo Role of kappa -opioid receptor activation in pharmacological preconditioning of swine Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2091 - H2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Bovill Anesthesia for Patients with Impaired Ventricular Function Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 49 - 54. [PDF] |
||||
![]() |
K. Shinmura, M. Nagai, K. Tamaki, M. Tani, and R. Bolli COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2534 - H2543. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kodani, Y.-T. Xuan, K. Shinmura, H. Takano, X.-L. Tang, and R. Bolli delta -Opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1943 - H1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kato and P. Foex Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists: [La protection myocardique contre les lesions d'ischemie-reperfusion par des anesthesiques : une mise a jour pour les anesthesiologistes] Can J Anesth, October 1, 2002; 49(8): 777 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Piriou, P. Chiari, F. Lhuillier, O. Bastien, J. Loufoua, O. Raisky, J. S. David, M. Ovize, and J.-J. Lehot Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium{dagger} Br. J. Anaesth., September 1, 2002; 89(3): 486 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Fryer, J. A Auchampach, and G. J Gross Therapeutic receptor targets of ischemic preconditioning Cardiovasc Res, August 15, 2002; 55(3): 520 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wu, Y. Soong, G.-M. Zhao, and H. H. Szeto A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H783 - H791. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Sigg, J. A. Coles Jr., P. R. Oeltgen, and P. A. Iaizzo Role of delta -opioid receptor agonists on infarct size reduction in swine Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1953 - H1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. A. Menown and A. A. J. Adgey Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1651 - 1653. [Full Text] [PDF] |
||||
![]() |
M. Karck, S. Tanaka, S. F. Bolling, A. Simon, T.-P. Su, P. R. Oeltgen, and A. Haverich Myocardial protection by ischemic preconditioning and {delta}-opioid receptor activation in the isolated working rat heart J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 986 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Sigg, J. A. Coles Jr, W. J. Gallagher, P. R. Oeltgen, and P. A. Iaizzo Opioid preconditioning: myocardial function and energy metabolism Ann. Thorac. Surg., November 1, 2001; 72(5): 1576 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Raeburn, J. C. Cleveland Jr, M. A. Zimmerman, and A. H. Harken Organ Preconditioning Arch Surg, November 1, 2001; 136(11): 1263 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, P. Gres, and G. Heusch Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2175 - H2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fryer, P. F. Pratt, A. K. Hsu, and G. J. Gross Differential Activation of Extracellular Signal Regulated Kinase Isoforms in Preconditioning and Opioid-Induced Cardioprotection J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 642 - 649. [Abstract] [Full Text] |
||||
![]() |
R. M. Fryer, Y. Wang, A. K. Hsu, and G. J. Gross Essential activation of PKC-{delta} in opioid-initiated cardioprotection Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1346 - H1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krenz, C. P. Baines, X.-M. Yang, G. Heusch, M. V. Cohen, and J. M. Downey Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia J. Am. Coll. Cardiol., February 1, 2001; 37(2): 601 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. LEE and C. W. EMALA Protein Kinase C and Gi/o Proteins Are Involved in Adenosine- and Ischemic Preconditioning--Mediated Renal Protection J. Am. Soc. Nephrol., February 1, 2001; 12(2): 233 - 240. [Abstract] [Full Text] |
||||
![]() |
J. Huh, G. J. Gross, H. Nagase, and B. T. Liang Protection of cardiac myocytes via {delta}1-opioid receptors, protein kinase C, and mitochondrial KATP channels Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H377 - H383. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Y. Wang, S. Wu, J.-M. Pei, X.-C. Yu, and T.-M. Wong {kappa}- but not {delta}-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H384 - H391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Bell, M. N. Sack, A. Patel, L. H. Opie, and D. M. Yellon Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2296 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Younes, S. Pepe, B. A. Barron, H. A. Spurgeon, E. G. Lakatta, and J. L. Caffrey Cardiac synthesis, processing, and coronary release of enkephalin-related peptides Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1989 - H1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Saltman, I. B. Krukenkamp, G. R. Gaudette, H. Horimoto, and S. Levitsky Pharmacological preconditioning with the adenosine triphosphate-sensitive potassium channel opener pinacidil Ann. Thorac. Surg., August 1, 2000; 70(2): 595 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Gaudette, I. B. Krukenkamp, A. E. Saltman, H. Horimoto, and S. Levitsky Preconditioning with PKC and the ATP-sensitive potassium channels: a codependent relationship Ann. Thorac. Surg., August 1, 2000; 70(2): 602 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fryer, A. K. Hsu, H. Nagase, and G. J. Gross Opioid-Induced Cardioprotection against Myocardial Infarction and Arrhythmias: Mitochondrial versus Sarcolemmal ATP-Sensitive Potassium Channels J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 451 - 457. [Abstract] [Full Text] |
||||
![]() |
W. E. Johnston Preconditioning the Brain and Heart: Implications for Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79. [Abstract] [PDF] |
||||
![]() |
D M Yellon and G F Baxter Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart, April 1, 2000; 83(4): 381 - 387. [Full Text] |
||||
![]() |
H. T. Lee and C. W. Emala Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors Am J Physiol Renal Physiol, March 1, 2000; 278(3): F380 - F387. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takasaki, R. A. Wolff, G. L. Chien, and D. M. van Winkle Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta -opioid receptors Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2442 - H2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Belhomme, J. Peynet, M. Louzy, J.-M. Launay, M. Kitakaze, and P. Menasche Evidence for Preconditioning by Isoflurane in Coronary Artery Bypass Graft Surgery Circulation, November 9, 1999; 100(90002): II-340 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Benedict, M. B. Benedict, T.-P. Su, and S. F. Bolling Opiate Drugs and {delta}-Receptor-Mediated Myocardial Protection Circulation, November 9, 1999; 100(90002): II-357 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Jahania, J. A. Sanchez, P. Narayan, R. D. Lasley, and R. M. Mentzer Jr Heart preservation for transplantation: principles and strategies Ann. Thorac. Surg., November 1, 1999; 68(5): 1983 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Perrault and P. Menasche Preconditioning: can nature’s shield be raised against surgical ischemic-reperfusion injury? Ann. Thorac. Surg., November 1, 1999; 68(5): 1988 - 1994. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. V. Chen, S. C. Body, and S. K. Shernan Myocardial Preconditioning: Characteristics, Mechanisms, and Clinical Applications Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 85 - 97. [Abstract] [PDF] |
||||
![]() |
B. T. Liang and G. J. Gross Direct Preconditioning of Cardiac Myocytes via Opioid Receptors and KATP Channels Circ. Res., June 25, 1999; 84(12): 1396 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kevelaitis, J. Peynet, C. Mouas, J.-M. Launay, and P. Menasche Opening of Potassium Channels : The Common Cardioprotective Link Between Preconditioning and Natural Hibernation? Circulation, June 15, 1999; 99(23): 3079 - 3085. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tomai, F. Crea, A. Gaspardone, F. Versaci, A. S. Ghini, C. Ferri, G. Desideri, L. Chiariello, and P. A. Gioffre Effects of naloxone on myocardial ischemic preconditioning in humans J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1863 - 1869. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-L. Wang, H. Chang, C.-R. Hung, and Y.-Z. Tseng Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction Cardiovasc Res, December 1, 1998; 40(3): 557 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. J. Schultz, A. K. Hsu, and G. J. Gross Ischemic Preconditioning in the Intact Rat Heart Is Mediated by {delta}1- But Not µ- or {kappa}-Opioid Receptors Circulation, April 7, 1998; 97(13): 1282 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. J. Schultz, A. K. Hsu, H. Nagase, and G. J. Gross TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H909 - H914. [Abstract] [Full Text] [PDF] |
||||
![]() |
|